1 |
CDK4
| 5件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Tight junction, T cell receptor signaling pathway, Viral carcinogenesis, Small cell lung cancer | D10688
D10688
|
Abemaciclib
| 1件: 34 34 |
2 |
CDK6
| 3件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Viral carcinogenesis, Small cell lung cancer | D10688
D10688
|
Abemaciclib
| 1件: 34 34 |
3 |
CHRM1
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D00113
D00113
|
Atropine
| 2件: 2 2, 299 |
4 |
CHRM1
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D00138
D00138
|
Scopolamine
| 1件: 2 2 |
5 |
CHRM1
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D00270
D00270
|
Chlorpromazine
| 1件: 254 254 |
6 |
CHRM1
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D00397
D00397
|
Tropicamide
| 1件: 6 6 |
7 |
CHRM1
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D00465
D00465
|
Oxybutynin
| 3件: 6 6, 13, 53 |
8 |
CHRM1
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D08441
D08441
|
Propiverine
| 1件: 226 226 |
9 |
CHRM1
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D08638
D08638
|
Trihexyphenidyl
| 2件: 5 5, 6 |
10 |
CHRM1
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D11383
D11383
|
Blarcamesine
| 1件: 156 156 |
11 |
CHRM2
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D00113
D00113
|
Atropine
| 2件: 2 2, 299 |
12 |
CHRM2
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D00138
D00138
|
Scopolamine
| 1件: 2 2 |
13 |
CHRM2
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D00270
D00270
|
Chlorpromazine
| 1件: 254 254 |
14 |
CHRM2
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D00397
D00397
|
Tropicamide
| 1件: 6 6 |
15 |
CHRM2
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D00465
D00465
|
Oxybutynin
| 3件: 6 6, 13, 53 |
16 |
CHRM2
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D00525
D00525
|
Pilocarpine
| 3件: 6 6, 53, 299 |
17 |
CHRM2
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D07226
D07226
|
Fesoterodine
| 1件: 6 6 |
18 |
CHRM2
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D08441
D08441
|
Propiverine
| 1件: 226 226 |
19 |
CHRM2
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D08638
D08638
|
Trihexyphenidyl
| 2件: 5 5, 6 |
20 |
CHRM2
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D11383
D11383
|
Blarcamesine
| 1件: 156 156 |
21 |
CSF1R
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer | D08552
D08552
|
Sunitinib
| 2件: 28 28, 34 |
22 |
CSF1R
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer | D11270
D11270
|
Pexidartinib
| 1件: 34 34 |
23 |
CSF3R
| 1件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway | D03235
D03235
|
Filgrastim
| 35件: 2 2, 6, 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
24 |
CSF3R
| 1件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway | D03247
D03247
|
Lenograstim
| 7件: 2 2, 13, 16, 18, 19, 57, 65 |
25 |
CSF3R
| 1件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway | D06889
D06889
|
Pegfilgrastim
| 1件: 60 60 |
26 |
EGFR
| 8件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer | D01977
D01977
|
Gefitinib
| 1件: 75 75 |
27 |
EGFR
| 8件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer | D03455
D03455
|
Cetuximab
| 2件: 51 51, 86 |
28 |
EGFR
| 8件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer | D07907
D07907
|
Erlotinib
| 1件: 94 94 |
29 |
EGFR
| 8件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer | D08108
D08108
|
Lapatinib
| 3件: 34 34, 74, 75 |
30 |
EGFR
| 8件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer | D08950
D08950
|
Neratinib
| 1件: 34 34 |
31 |
EGFR
| 8件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer | D11251
D11251
|
Icotinib
| 1件: 34 34 |
32 |
EGFR
| 8件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer | D11772
D11772
|
Tesevatinib
| 1件: 67 67 |
33 |
EPHA2
| 3件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway | D03658
D03658
|
Dasatinib
| 2件: 51 51, 85 |
34 |
EPHA2
| 3件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway | D06414
D06414
|
Dasatinib
| 2件: 51 51, 85 |
35 |
EPOR
| 1件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway | D09946
D09946
|
Peginesatide
| 1件: 283 283 |
36 |
ERBB2
| 5件: Platinum drug resistance Platinum drug resistance, PI3K-Akt signaling pathway, Tight junction, Proteoglycans in cancer, Prostate cancer | D08108
D08108
|
Lapatinib
| 3件: 34 34, 74, 75 |
37 |
ERBB2
| 5件: Platinum drug resistance Platinum drug resistance, PI3K-Akt signaling pathway, Tight junction, Proteoglycans in cancer, Prostate cancer | D08950
D08950
|
Neratinib
| 1件: 34 34 |
38 |
ERBB2
| 5件: Platinum drug resistance Platinum drug resistance, PI3K-Akt signaling pathway, Tight junction, Proteoglycans in cancer, Prostate cancer | D11772
D11772
|
Tesevatinib
| 1件: 67 67 |
39 |
ERBB4
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Proteoglycans in cancer | D08950
D08950
|
Neratinib
| 1件: 34 34 |
40 |
FGFR1
| 8件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Regulation of actin cytoskeleton, Proteoglycans in cancer, Prostate cancer | D10481
D10481
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 |
41 |
FGFR1
| 8件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Regulation of actin cytoskeleton, Proteoglycans in cancer, Prostate cancer | D11589
D11589
|
Infigratinib
| 1件: 276 276 |
42 |
FGFR3
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton | D10481
D10481
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 |
43 |
FGFR3
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton | D11589
D11589
|
Infigratinib
| 1件: 276 276 |
44 |
FGFR2
| 6件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Prostate cancer | D05338
D05338
|
Palifermin
| 5件: 13 13, 36, 38, 39, 65 |
45 |
FGFR2
| 6件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Prostate cancer | D10481
D10481
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 |
46 |
FGFR2
| 6件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Prostate cancer | D11589
D11589
|
Infigratinib
| 1件: 276 276 |
47 |
FLT1
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis | D03218
D03218
|
Axitinib
| 1件: 34 34 |
48 |
FLT1
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis | D08552
D08552
|
Sunitinib
| 2件: 28 28, 34 |
49 |
FLT1
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis | D08881
D08881
|
Cediranib
| 1件: 34 34 |
50 |
FLT1
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer, Rheumatoid arthritis | D10481
D10481
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 |
51 |
FLT3
| 3件: Ras signaling pathway Ras signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer | D08524
D08524
|
Sorafenib
| 2件: 34 34, 86 |
52 |
FLT3
| 3件: Ras signaling pathway Ras signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer | D08552
D08552
|
Sunitinib
| 2件: 28 28, 34 |
53 |
FLT3
| 3件: Ras signaling pathway Ras signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer | D11270
D11270
|
Pexidartinib
| 1件: 34 34 |
54 |
FLT4
| 3件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway | D03218
D03218
|
Axitinib
| 1件: 34 34 |
55 |
FLT4
| 3件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway | D08524
D08524
|
Sorafenib
| 2件: 34 34, 86 |
56 |
FLT4
| 3件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway | D08552
D08552
|
Sunitinib
| 2件: 28 28, 34 |
57 |
FLT4
| 3件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway | D08881
D08881
|
Cediranib
| 1件: 34 34 |
58 |
FLT4
| 3件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway | D10481
D10481
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 |
59 |
FLT4
| 3件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway | D11772
D11772
|
Tesevatinib
| 1件: 67 67 |
60 |
MTOR
| 9件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Proteoglycans in cancer, Prostate cancer | D00753
D00753
|
Sirolimus
| 40件: 2 2, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 |
61 |
MTOR
| 9件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Proteoglycans in cancer, Prostate cancer | D02714
D02714
|
Everolimus
| 9件: 34 34, 67, 89, 96, 137, 157, 158, 228, 277 |
62 |
MTOR
| 9件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Proteoglycans in cancer, Prostate cancer | D06068
D06068
|
Temsirolimus
| 1件: 13 13 |
63 |
GHR
| 1件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway | D03297
D03297
|
Mecasermin
| 6件: 65 65, 78, 96, 168, 265, 299 |
64 |
GHR
| 1件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway | D05394
D05394
|
Pegvisomant
| 2件: 78 78, 265 |
65 |
GHR
| 1件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway | D11193
D11193
|
Somavaratan
| 1件: 78 78 |
66 |
GHR
| 1件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway | D11194
D11194
|
Somapacitan
| 2件: 78 78, 195 |
67 |
GHR
| 1件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway | D11486
D11486
|
Lonapegsomatropin
| 1件: 78 78 |
68 |
IFNA1
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09662
D09662
|
Rontalizumab
| 1件: 49 49 |
69 |
IFNA1
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09668
D09668
|
Sifalimumab
| 1件: 49 49 |
70 |
IFNA2
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09662
D09662
|
Rontalizumab
| 1件: 49 49 |
71 |
IFNA2
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09668
D09668
|
Sifalimumab
| 1件: 49 49 |
72 |
IFNA4
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09662
D09662
|
Rontalizumab
| 1件: 49 49 |
73 |
IFNA4
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09668
D09668
|
Sifalimumab
| 1件: 49 49 |
74 |
IFNA5
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09662
D09662
|
Rontalizumab
| 1件: 49 49 |
75 |
IFNA5
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09668
D09668
|
Sifalimumab
| 1件: 49 49 |
76 |
IFNA6
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09662
D09662
|
Rontalizumab
| 1件: 49 49 |
77 |
IFNA6
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09668
D09668
|
Sifalimumab
| 1件: 49 49 |
78 |
IFNA7
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09662
D09662
|
Rontalizumab
| 1件: 49 49 |
79 |
IFNA7
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09668
D09668
|
Sifalimumab
| 1件: 49 49 |
80 |
IFNA8
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09662
D09662
|
Rontalizumab
| 1件: 49 49 |
81 |
IFNA8
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09668
D09668
|
Sifalimumab
| 1件: 49 49 |
82 |
IFNA10
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09662
D09662
|
Rontalizumab
| 1件: 49 49 |
83 |
IFNA10
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09668
D09668
|
Sifalimumab
| 1件: 49 49 |
84 |
IFNA13
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09662
D09662
|
Rontalizumab
| 1件: 49 49 |
85 |
IFNA13
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09668
D09668
|
Sifalimumab
| 1件: 49 49 |
86 |
IFNA14
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09662
D09662
|
Rontalizumab
| 1件: 49 49 |
87 |
IFNA14
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09668
D09668
|
Sifalimumab
| 1件: 49 49 |
88 |
IFNA16
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09662
D09662
|
Rontalizumab
| 1件: 49 49 |
89 |
IFNA16
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09668
D09668
|
Sifalimumab
| 1件: 49 49 |
90 |
IFNA17
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09662
D09662
|
Rontalizumab
| 1件: 49 49 |
91 |
IFNA17
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09668
D09668
|
Sifalimumab
| 1件: 49 49 |
92 |
IFNA21
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09662
D09662
|
Rontalizumab
| 1件: 49 49 |
93 |
IFNA21
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis | D09668
D09668
|
Sifalimumab
| 1件: 49 49 |
94 |
IFNAR1
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway | D00745
D00745
|
Interferon alfa-2a
| 1件: 56 56 |
95 |
IFNAR1
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway | D00746
D00746
|
Interferon beta-1b
| 1件: 13 13 |
96 |
IFNAR1
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway | D02745
D02745
|
Interferon alfa-2b
| 2件: 25 25, 34 |
97 |
IFNAR1
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway | D03305
D03305
|
Interferon alfa
| 6件: 13 13, 25, 26, 28, 56, 96 |
98 |
IFNAR1
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway | D04554
D04554
|
Interferon beta-1a
| 4件: 13 13, 26, 96, 97 |
99 |
IFNAR1
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway | D10483
D10483
|
Peginterferon beta-1a
| 1件: 13 13 |
100 |
IFNAR1
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway | D11082
D11082
|
Anifrolumab
| 3件: 46 46, 49, 53 |
101 |
IFNAR2
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway | D00745
D00745
|
Interferon alfa-2a
| 1件: 56 56 |
102 |
IFNAR2
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway | D00746
D00746
|
Interferon beta-1b
| 1件: 13 13 |
103 |
IFNAR2
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway | D02745
D02745
|
Interferon alfa-2b
| 2件: 25 25, 34 |
104 |
IFNAR2
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway | D03305
D03305
|
Interferon alfa
| 6件: 13 13, 25, 26, 28, 56, 96 |
105 |
IFNAR2
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway | D04554
D04554
|
Interferon beta-1a
| 4件: 13 13, 26, 96, 97 |
106 |
IFNAR2
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway | D10483
D10483
|
Peginterferon beta-1a
| 1件: 13 13 |
107 |
IFNAR2
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Toll-like receptor signaling pathway | D11082
D11082
|
Anifrolumab
| 3件: 46 46, 49, 53 |
108 |
IGF1R
| 8件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Progesterone-mediated oocyte maturation, Transcriptional misregulation in cancer, Proteoglycans in cancer, Prostate cancer | D03297
D03297
|
Mecasermin
| 6件: 65 65, 78, 96, 168, 265, 299 |
109 |
IGF1R
| 8件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Progesterone-mediated oocyte maturation, Transcriptional misregulation in cancer, Proteoglycans in cancer, Prostate cancer | D09680
D09680
|
Teprotumumab
| 1件: 51 51 |
110 |
IGF1R
| 8件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Progesterone-mediated oocyte maturation, Transcriptional misregulation in cancer, Proteoglycans in cancer, Prostate cancer | D09925
D09925
|
Linsitinib
| 1件: 232 232 |
111 |
IL2RA
| 4件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation | D00748
D00748
|
Aldesleukin
| 6件: 2 2, 35, 49, 65, 96, 97 |
112 |
IL2RA
| 4件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation | D03058
D03058
|
Basiliximab
| 6件: 2 2, 50, 66, 97, 222, 228 |
113 |
IL2RA
| 4件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation | D03639
D03639
|
Daclizumab
| 8件: 13 13, 56, 60, 65, 97, 107, 283, 284 |
114 |
IL2RB
| 5件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer | D00748
D00748
|
Aldesleukin
| 6件: 2 2, 35, 49, 65, 96, 97 |
115 |
IL2RG
| 5件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Primary immunodeficiency | D00748
D00748
|
Aldesleukin
| 6件: 2 2, 35, 49, 65, 96, 97 |
116 |
IL4
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway | D03117
D03117
|
Binetrakin
| 1件: 46 46 |
117 |
IL4R
| 3件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation | D10354
D10354
|
Dupilumab
| 5件: 51 51, 97, 98, 160, 162 |
118 |
IL6
| 11件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer, Rheumatoid arthritis | D01583
D01583
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
119 |
IL6
| 11件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer, Rheumatoid arthritis | D08976
D08976
|
Pomalidomide
| 5件: 28 28, 51, 85, 227, 331 |
120 |
IL6
| 11件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer, Rheumatoid arthritis | D09669
D09669
|
Siltuximab
| 2件: 28 28, 331 |
121 |
IL6
| 11件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer, Rheumatoid arthritis | D10080
D10080
|
Sirukumab
| 2件: 41 41, 46 |
122 |
IL6
| 11件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer, Rheumatoid arthritis | D12487
D12487
|
Olokizumab
| 2件: 46 46, 96 |
123 |
IL6R
| 3件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th17 cell differentiation | D02596
D02596
|
Tocilizumab
| 21件: 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 |
124 |
IL6R
| 3件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th17 cell differentiation | D10161
D10161
|
Sarilumab
| 5件: 41 41, 46, 84, 107, 271 |
125 |
IL6R
| 3件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th17 cell differentiation | D11079
D11079
|
Satralizumab
| 3件: 11 11, 13, 86 |
126 |
INSR
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus | D03230
D03230
|
Insulin human
| 2件: 96 96, 156 |
127 |
INSR
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus | D03250
D03250
|
Insulin glargine
| 1件: 299 299 |
128 |
INSR
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus | D04539
D04539
|
Insulin detemir
| 1件: 299 299 |
129 |
ITGA4
| 3件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection | D06590
D06590
|
Firategrast
| 1件: 13 13 |
130 |
ITGA4
| 3件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection | D06886
D06886
|
Natalizumab
| 6件: 13 13, 15, 25, 46, 63, 96 |
131 |
ITGA4
| 3件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection | D08083
D08083
|
Vedolizumab
| 3件: 94 94, 96, 97 |
132 |
ITGA4
| 3件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection | D10540
D10540
|
Abrilumab
| 2件: 96 96, 97 |
133 |
ITGB7
| 3件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer | D08083
D08083
|
Vedolizumab
| 3件: 94 94, 96, 97 |
134 |
ITGB7
| 3件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer | D09901
D09901
|
Etrolizumab
| 2件: 96 96, 97 |
135 |
ITGB7
| 3件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer | D10540
D10540
|
Abrilumab
| 2件: 96 96, 97 |
136 |
JAK1
| 7件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis | D09959
D09959
|
Ruxolitinib
| 3件: 60 60, 65, 228 |
137 |
JAK1
| 7件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis | D09970
D09970
|
Tofacitinib
| 15件: 11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 |
138 |
JAK1
| 7件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis | D10308
D10308
|
Baricitinib
| 13件: 2 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 |
139 |
JAK1
| 7件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis | D10653
D10653
|
Peficitinib
| 1件: 46 46 |
140 |
JAK1
| 7件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis | D10871
D10871
|
Filgotinib
| 6件: 46 46, 53, 96, 97, 222, 271 |
141 |
JAK1
| 7件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis | D10944
D10944
|
Itacitinib
| 4件: 46 46, 51, 97, 228 |
142 |
JAK1
| 7件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis | D10994
D10994
|
Upadacitinib
| 8件: 40 40, 41, 46, 49, 96, 97, 107, 271 |
143 |
JAK1
| 7件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis | D11400
D11400
|
Abrocitinib
| 1件: 84 84 |
144 |
JAK2
| 7件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Prolactin signaling pathway, Toxoplasmosis, Tuberculosis | D09959
D09959
|
Ruxolitinib
| 3件: 60 60, 65, 228 |
145 |
JAK2
| 7件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Prolactin signaling pathway, Toxoplasmosis, Tuberculosis | D09970
D09970
|
Tofacitinib
| 15件: 11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 |
146 |
JAK2
| 7件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Prolactin signaling pathway, Toxoplasmosis, Tuberculosis | D10308
D10308
|
Baricitinib
| 13件: 2 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 |
147 |
JAK2
| 7件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Prolactin signaling pathway, Toxoplasmosis, Tuberculosis | D10653
D10653
|
Peficitinib
| 1件: 46 46 |
148 |
JAK3
| 6件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis, Primary immunodeficiency | D09970
D09970
|
Tofacitinib
| 15件: 11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 |
149 |
JAK3
| 6件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis, Primary immunodeficiency | D10653
D10653
|
Peficitinib
| 1件: 46 46 |
150 |
KDR
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer | D03218
D03218
|
Axitinib
| 1件: 34 34 |
151 |
KDR
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer | D08524
D08524
|
Sorafenib
| 2件: 34 34, 86 |
152 |
KDR
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer | D08552
D08552
|
Sunitinib
| 2件: 28 28, 34 |
153 |
KDR
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer | D08881
D08881
|
Cediranib
| 1件: 34 34 |
154 |
KDR
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer | D10062
D10062
|
Cabozantinib
| 1件: 34 34 |
155 |
KDR
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer | D10481
D10481
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 |
156 |
KDR
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Proteoglycans in cancer | D11772
D11772
|
Tesevatinib
| 1件: 67 67 |
157 |
KIT
| 3件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway | D03658
D03658
|
Dasatinib
| 2件: 51 51, 85 |
158 |
KIT
| 3件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway | D06414
D06414
|
Dasatinib
| 2件: 51 51, 85 |
159 |
KIT
| 3件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway | D08066
D08066
|
Imatinib
| 12件: 13 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 |
160 |
KIT
| 3件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway | D08524
D08524
|
Sorafenib
| 2件: 34 34, 86 |
161 |
KIT
| 3件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway | D08552
D08552
|
Sunitinib
| 2件: 28 28, 34 |
162 |
KIT
| 3件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway | D08953
D08953
|
Nilotinib
| 5件: 6 6, 8, 34, 51, 86 |
163 |
KIT
| 3件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway | D10229
D10229
|
Masitinib
| 6件: 2 2, 5, 6, 13, 46, 96 |
164 |
KIT
| 3件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway | D11270
D11270
|
Pexidartinib
| 1件: 34 34 |
165 |
MET
| 6件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer, Proteoglycans in cancer, Renal cell carcinoma | D10062
D10062
|
Cabozantinib
| 1件: 34 34 |
166 |
NFKB1
| 20件: Ras signaling pathway Ras signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Prolactin signaling pathway, Relaxin signaling pathway, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis, Prostate cancer, Small cell lung cancer | D01146
D01146
|
Iguratimod
| 5件: 46 46, 51, 53, 271, 300 |
167 |
NGF
| 3件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway | D09387
D09387
|
Tanezumab
| 2件: 226 226, 298 |
168 |
NGFR
| 5件: Virion - Lyssavirus Virion - Lyssavirus, Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Transcriptional misregulation in cancer | D11028
D11028
|
Cenegermin
| 2件: 53 53, 90 |
169 |
PDGFRA
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D08066
D08066
|
Imatinib
| 12件: 13 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 |
170 |
PDGFRA
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D08552
D08552
|
Sunitinib
| 2件: 28 28, 34 |
171 |
PDGFRA
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D08953
D08953
|
Nilotinib
| 5件: 6 6, 8, 34, 51, 86 |
172 |
PDGFRA
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D10481
D10481
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 |
173 |
PDGFRB
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D03658
D03658
|
Dasatinib
| 2件: 51 51, 85 |
174 |
PDGFRB
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D06414
D06414
|
Dasatinib
| 2件: 51 51, 85 |
175 |
PDGFRB
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D08524
D08524
|
Sorafenib
| 2件: 34 34, 86 |
176 |
PDGFRB
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D08552
D08552
|
Sunitinib
| 2件: 28 28, 34 |
177 |
PDGFRB
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D08953
D08953
|
Nilotinib
| 5件: 6 6, 8, 34, 51, 86 |
178 |
PDGFRB
| 5件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D10481
D10481
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 |
179 |
PGF
| 3件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway | D09574
D09574
|
Aflibercept
| 2件: 90 90, 166 |
180 |
PIK3CA
| 28件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11011
D11011
|
Alpelisib
| 1件: 138 138 |
181 |
PIK3CA
| 28件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
182 |
PIK3CB
| 28件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
183 |
PIK3CD
| 28件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
184 |
PIK3CD
| 28件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11437
D11437
|
Parsaclisib
| 3件: 35 35, 53, 61 |
185 |
PRKAA1
| 3件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Tight junction, Thermogenesis | D04966
D04966
|
Metformin
| 25件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301 |
186 |
PRKAA2
| 3件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Tight junction, Thermogenesis | D04966
D04966
|
Metformin
| 25件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301 |
187 |
MAP2K1
| 22件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D09666
D09666
|
Selumetinib
| 1件: 34 34 |
188 |
MAP2K1
| 22件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D10175
D10175
|
Trametinib
| 4件: 2 2, 34, 279, 280 |
189 |
MAP2K1
| 22件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D10405
D10405
|
Cobimetinib
| 1件: 280 280 |
190 |
MAP2K1
| 22件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D10604
D10604
|
Binimetinib
| 1件: 34 34 |
191 |
MAP2K1
| 22件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D11675
D11675
|
Mirdametinib
| 1件: 34 34 |
192 |
MAP2K2
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D09666
D09666
|
Selumetinib
| 1件: 34 34 |
193 |
MAP2K2
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D10175
D10175
|
Trametinib
| 4件: 2 2, 34, 279, 280 |
194 |
MAP2K2
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D10405
D10405
|
Cobimetinib
| 1件: 280 280 |
195 |
MAP2K2
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D10604
D10604
|
Binimetinib
| 1件: 34 34 |
196 |
MAP2K2
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D11675
D11675
|
Mirdametinib
| 1件: 34 34 |
197 |
PRL
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Prolactin signaling pathway | D00987
D00987
|
Cabergoline
| 3件: 6 6, 74, 75 |
198 |
PRL
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Prolactin signaling pathway | D01348
D01348
|
Terguride
| 2件: 51 51, 86 |
199 |
PRL
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Prolactin signaling pathway | D03165
D03165
|
Bromocriptine
| 2件: 6 6, 74 |
200 |
RAF1
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, T cell receptor signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Tuberculosis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer | D08524
D08524
|
Sorafenib
| 2件: 34 34, 86 |
201 |
BCL2
| 10件: Platinum drug resistance Platinum drug resistance, Sphingolipid signaling pathway, Protein processing in endoplasmic reticulum, PI3K-Akt signaling pathway, Shigellosis, Salmonella infection, Toxoplasmosis, Tuberculosis, Prostate cancer, Small cell lung cancer | D10679
D10679
|
Venetoclax
| 1件: 28 28 |
202 |
RELA
| 20件: Ras signaling pathway Ras signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Prolactin signaling pathway, Relaxin signaling pathway, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis, Prostate cancer, Small cell lung cancer | D12181
D12181
|
Edasalonexent
| 1件: 113 113 |
203 |
RXRA
| 7件: PPAR signaling pathway PPAR signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer | D02754
D02754
|
Acitretin
| 1件: 37 37 |
204 |
RXRA
| 7件: PPAR signaling pathway PPAR signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer | D02815
D02815
|
Alitretinoin
| 1件: 49 49 |
205 |
RXRA
| 7件: PPAR signaling pathway PPAR signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer | D03106
D03106
|
Bexarotene
| 2件: 13 13, 75 |
206 |
SYK
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis | D09347
D09347
|
Fostamatinib
| 4件: 46 46, 49, 61, 66 |
207 |
VEGFA
| 8件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Relaxin signaling pathway, Proteoglycans in cancer, Renal cell carcinoma, Rheumatoid arthritis | D05697
D05697
|
Ranibizumab
| 4件: 34 34, 166, 227, 301 |
208 |
VEGFA
| 8件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Relaxin signaling pathway, Proteoglycans in cancer, Renal cell carcinoma, Rheumatoid arthritis | D06409
D06409
|
Bevacizumab
| 6件: 13 13, 34, 85, 87, 227, 280 |
209 |
VEGFA
| 8件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Relaxin signaling pathway, Proteoglycans in cancer, Renal cell carcinoma, Rheumatoid arthritis | D09574
D09574
|
Aflibercept
| 2件: 90 90, 166 |
210 |
VEGFB
| 4件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Relaxin signaling pathway | D09574
D09574
|
Aflibercept
| 2件: 90 90, 166 |
211 |
VWF
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Platelet activation | D11160
D11160
|
Caplacizumab
| 1件: 64 64 |
212 |
FGF23
| 4件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton | D10913
D10913
|
Burosumab
| 1件: 238 238 |
213 |
CASP9
| 10件: Platinum drug resistance Platinum drug resistance, PI3K-Akt signaling pathway, VEGF signaling pathway, Thyroid hormone signaling pathway, Prion disease, Toxoplasmosis, Tuberculosis, Prostate cancer, Small cell lung cancer, Viral myocarditis | D11195
D11195
|
Rimiducid
| 6件: 19 19, 60, 65, 284, 285, 326 |
214 |
CD19
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Primary immunodeficiency | D11496
D11496
|
Obexelimab
| 1件: 300 300 |
215 |
CD19
| 2件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Primary immunodeficiency | D11757
D11757
|
Inebilizumab
| 4件: 11 11, 13, 51, 300 |